Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get trading ideas, historical data, advanced options screeners, more. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Integra Lifesciences (IART)

Integra Lifesciences (IART)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,639,939
  • Shares Outstanding, K 83,504
  • Annual Sales, $ 1,542 M
  • Annual Income, $ 169,080 K
  • 60-Month Beta 1.12
  • Price/Sales 2.35
  • Price/Cash Flow 9.22
  • Price/Book 2.18
Trade IART with:

Options Overview Details

View History
  • Implied Volatility 31.39% ( -18.59%)
  • Historical Volatility 25.18%
  • IV Percentile 10%
  • IV Rank 21.62%
  • IV High 59.67% on 07/07/22
  • IV Low 23.59% on 11/08/21
  • Put/Call Vol Ratio 0.00
  • Today's Volume 20
  • Volume Avg (30-Day) 8
  • Put/Call OI Ratio 5.55
  • Today's Open Interest 321
  • Open Int (30-Day) 1,502

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/22
See More
  • Average Estimate 0.73
  • Number of Estimates 4
  • High Estimate 0.79
  • Low Estimate 0.71
  • Prior Year 0.86
  • Growth Rate Est. (year over year) -15.12%

Price Performance

See More
Period Period Low Period High Performance
1-Month
43.00 +1.37%
on 09/23/22
50.79 -14.18%
on 08/25/22
-8.26 (-15.93%)
since 08/23/22
3-Month
43.00 +1.37%
on 09/23/22
57.80 -24.58%
on 08/17/22
-10.31 (-19.13%)
since 06/23/22
52-Week
43.00 +1.37%
on 09/23/22
74.98 -41.86%
on 11/02/21
-28.74 (-39.73%)
since 09/23/21

Most Recent Stories

More News
Here's Why Investors Should Retain Integra (IART) Stock for Now

Investors are optimistic about Integra's (IART) better-than-expected results and the continued demand for its products.

MCK : 343.27 (-1.06%)
IART : 43.59 (+0.46%)
AMN : 103.95 (-0.15%)
SWAV : 252.08 (-2.61%)
Penumbra (PEN) Surges 6.2%: Is This an Indication of Further Gains?

Penumbra (PEN) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

PEN : 184.94 (+2.52%)
IART : 43.59 (+0.46%)
Integra (IART) Q2 Earnings Top, 2022 Adjusted EPS View Cut

Integr's (IART) year-over-year growth in both the CSS and Tissue Technology segments buoys optimism.

IART : 43.59 (+0.46%)
STE : 167.29 (-5.36%)
GKOS : 50.39 (-1.91%)
SWAV : 252.08 (-2.61%)
Integra LifeSciences (IART) Tops Q2 Earnings and Revenue Estimates

Integra (IART) delivered earnings and revenue surprises of 2.50% and 0.83%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

IART : 43.59 (+0.46%)
SGHT : 6.61 (-1.05%)
Integra LifeSciences Reports Second Quarter 2022 Financial Results

PRINCETON, N.J., July 27, 2022 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company,...

IART : 43.59 (+0.46%)
Stocks Climb Ahead of Mega-Cap Tech Quarterly Earnings

Morning Markets September S&P 500 futures (ESU22 ) this morning are up +0.32%. U.S. stock index futures this morning are moderately higher as corporate earnings’ optimism outweighs concerns about a...

ESZ22 : 3,677.50 (-0.85%)
TSLA : 275.33 (-4.59%)
CMRX : 1.8200 (-4.21%)
TNXP : 0.5499 (-3.34%)
SIGA : 10.28 (-1.53%)
INO : 1.7100 (-3.39%)
IART : 43.59 (+0.46%)
IE : 8.05 (-9.14%)
MP : 28.89 (-5.43%)
IEA : 13.96 (-1.13%)
SNAP : 10.32 (-1.34%)
MARA : 9.47 (-9.98%)
Integra LifeSciences (IART) Reports Next Week: Wall Street Expects Earnings Growth

Integra (IART) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

IART : 43.59 (+0.46%)
Integra LifeSciences Appoints Renee Lo as Director

PRINCETON, N.J., July 19, 2022 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company,...

IART : 43.59 (+0.46%)
Integra LifeSciences to Host Second Quarter 2022 Financial Results Conference Call on July 27, 2022

PRINCETON, N.J., July 01, 2022 (GLOBE NEWSWIRE) -- )Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology...

IART : 43.59 (+0.46%)
Artivion (AORT) Soars 10.2%: Is Further Upside Left in the Stock?

Artivion (AORT) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in...

AORT : 13.31 (-28.05%)
IART : 43.59 (+0.46%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

Integra LifeSciences is one of the world leaders in regenerative medicine. The company develops, manufactures and markets cost-effective surgical implants and medical instruments. The company now manufactures and sells products in the following two global reportable business segments: Codman Specialty...

See More

Key Turning Points

3rd Resistance Point 44.61
2nd Resistance Point 44.17
1st Resistance Point 43.88
Last Price 43.59
1st Support Level 43.15
2nd Support Level 42.71
3rd Support Level 42.42

See More

52-Week High 74.98
Fibonacci 61.8% 62.76
Fibonacci 50% 58.99
Fibonacci 38.2% 55.22
Last Price 43.59
52-Week Low 43.00

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar